Clinical Trials List
2022-10-01 - 2026-12-31
Phase III
Not yet recruiting3
Recruiting4
ICD-10C79.81
Secondary malignant neoplasm of breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9198.81
Secondary malignant neoplasm of breast
-
-
Trial Applicant
GILEAD SCIENCES HONG KONG LIMITED
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Tsu-Yi Chao 未分科
- KA-WAI TAM Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- 莊博雅 Division of Hematology & Oncology
- 蘇智銘 Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 周旭桓 Division of General Surgery
- Chan-Keng Yang Division of General Surgery
- Shin-Cheh Chen Division of General Surgery
- Yung-Chang Lin Division of General Surgery
- 何蕙余 Division of General Surgery
- Chi-Chang Yu Division of General Surgery
- Wen-Chi Shen Division of General Surgery
- 阮昱翔 Division of General Surgery
- 沈士哲 Division of General Surgery
- Mengting Peng Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Jui-Hung Tsai 未分科
- Yao-Lung Kuo 未分科
- Chun-Hui Lee 未分科
- Zhu-Jun Loh 未分科
- 楊舜如 未分科
- Kuo-Ting Lee 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Feng Hou Division of General Surgery
- 高理鈞 Division of General Surgery
- 高捷妮 Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 巫承哲 Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
- Shen Liang Shih Division of General Surgery
- Chung-Liang Li Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林燕淑 Division of General Surgery
- 馮晉榮 Division of General Surgery
- 陳柏方 Division of General Surgery
- Ta-Chung Chao Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 鄭涵方 Division of General Surgery
- 邱仁輝 Division of General Surgery
- Chun-Yu Liu Division of General Surgery
- Jiun-I Lai Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- 賴亦貞 Division of General Surgery
- 陳彥蓁 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 高婉真 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
Co-Principal Investigator
- YEN-SHEN LU Division of General Surgery
- 張端瑩 Division of General Surgery
- MING-YANG WANG Division of General Surgery
- 林季宏 Division of General Surgery
- Wei-Wu Chen Division of General Surgery
- 黃柏翔 Division of General Surgery
- 羅喬 Division of General Surgery
- 郭文宏 Division of General Surgery
- 陳怡君 未分科
- 林柏翰 Division of General Surgery
- 蔡立威 Division of General Surgery
- 陳怡君 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
440 participants
